Despite promising results obtained from in vitro and in vivo studies of tumor growth following TZD treatment, few reported studies (24–26) have examined the effect of a PPAR-γ ligand on the metastatic potential of cancer cells in an animal model and the underlying molecular mechanisms. This evidence concerns the gene PPARG and cancer.